Neoadjuvant Adriamycin Plus Cyclophosphamide Followed By Docetaxel (Ac4-D4) Vs 5-Fluorouracil, Epirubicin Plus Cyclophosphamide Followed By Docetaxel (Fec3-D3) In Stage Ii Or Iii Operable Breast Cancer : Randomized Phase Iii Neo-Shorter Trial (Nct02001506)
Cancer Research（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要